Altria Group, Inc.

61.97-1.31 (-2.07%)

Oct 29, 4:00:02 PM EDT · NYSE · MO · USD

Upcoming Earnings

Report date

Key Stats

Market Cap

104.10B

P/E (TTM)

11.99

Basic EPS (TTM)

5.17

Dividend Yield

0.06%

Recent Filings

8-K

Muñoz retires from Altria board

10/9/25Oct 9, 2025

Altria Group announced on October 9, 2025, that director George Muñoz will retire after his current term, skipping re-election at the May 14, 2026, annual meeting. Serving since 2004, Muñoz chaired the Compensation and Talent Development Committee while contributing to Audit, Executive, and Finance groups. His 20-year tenure brought key insights from investment banking and law. Altria's board loses a veteran voice.

8-K

Altria issues $1B notes

8/6/25Aug 6, 2025

Altria Group issued $500 million of 4.500% senior unsecured notes due 2030 and $500 million of 5.250% notes due 2035 on August 6, 2025, guaranteed by subsidiary Philip Morris USA. Interest payments start February 6, 2026, semiannually. The notes rank equally with existing senior debt. Proceeds use not specified.

8-K

Altria narrows EPS guidance upward

7/30/25Jul 30, 2025

Altria reported Q2 2025 adjusted diluted EPS of $1.44, up 8.3% from last year, fueled by oral tobacco growth from on! pouches while smokeable products faced volume declines. Revenues net of excise taxes edged up 0.2% to $5.3 billion. The company narrowed full-year adjusted EPS guidance to $5.35-$5.45, signaling 3.0%-5.0% growth. Oral tobacco margins hit 68.7%.

10-Q

Q2 FY2025 results

7/30/25Jul 30, 2025

Altria's Q2 FY2025 results showed net revenues dipping 1.7% y/y to $6.1B, yet operating income surged 27.5% y/y to $3.2B, buoyed by a $354M Skoal impairment in Q2 2024 that didn't repeat. Smokeable products faced 10.2% y/y shipment declines to 16.1B sticks amid e-vapor growth and income squeezes, but pricing hikes and lower settlement charges lifted adjusted OCI 4.2% y/y to $2.9B. Oral tobacco shipments held steady at 199M cans q/q, with on! pouches up 26.5% y/y, driving adjusted OCI up 10.9% y/y to $500M despite MST share erosion. Cash fell to $1.3B from $3.1B y/y after $600M repurchases and $3.5B dividends, while $24.7B debt (4.5% weighted rate) remains manageable with $3B revolver availability. Litigation risks persist, including ITC bans on NJOY ACE.

8-K

Altria extends credit facility

7/23/25Jul 23, 2025

Altria Group extended its $3.0 billion senior unsecured revolving credit facility by one year to October 24, 2029, effective July 23, 2025, maintaining all other terms intact. This move bolsters liquidity amid ongoing operations. Lenders include JPMorgan Chase and Citibank as agents. Extension secures funding runway.

About

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company offers cigarettes primarily under the Marlboro brand; large cigars and pipe tobacco under the Black & Mild brand; moist smokeless tobacco and oral tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands; oral nicotine pouches under the on! brand; and e-vapor products under the NJOY ACE brand. It sells its products to distributors, as well as large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

CEO

Mr. William F. Gifford Jr.

IPO

1/2/1962

Website

https://www.altria.com

Employees

6,200

Sector

Consumer Defensive

Industry

Tobacco